Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotricity Inc (NQ: BTCY )

1.060 +0.010 (+0.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,775
Open 1.090
Bid (Size) 1.050 (3)
Ask (Size) 1.090 (1)
Prev. Close 1.050
Today's Range 1.030 - 1.090
52wk Range 0.7007 - 4.271
Shares Outstanding 9,258,957
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships with Two Leading Home-Based Diagnostic Companies
Via ACCESSWIRE

Performance

YTD
-10.19%
-10.19%
1 Month
-28.38%
-28.38%
3 Month
-9.66%
-9.66%
6 Month
+11.58%
+11.58%
1 Year
-74.92%
-74.92%

More News

Read More
Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
Via ACCESSWIRE
Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
Via ACCESSWIRE
Biotricity Receives Health Canada Clearance for Biotres
Via ACCESSWIRE
Biotricity's Earnings Outlook
Via Benzinga
Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats
Via ACCESSWIRE
Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network
Via ACCESSWIRE
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities
Via ACCESSWIRE
Earnings Outlook For Biotricity
Via Benzinga
Biotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14th
Via ACCESSWIRE
LOBO EV and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Biotricity Accelerates Market Access by Partnering with Third Major Group Purchasing Organization, Expanding Market Reach to 90% of U.S. Hospitals
Via ACCESSWIRE
Biotricity Partners with Health Aid Africa to Provide Complementary Heart Health Screenings at Allegiant Stadium Concert
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Biotricity Unveils that Improved Margins Resulted from Latest Advancements to its Proprietary Cardiac AI Cloud Platform and Announces Plans for Continued Expansion of its Cardiac AI Cloud
Via ACCESSWIRE
Biotricity Partners with a Second Top Group Purchasing Organization - Positions Company for Expanded Market Access to 1 out of every 2 Hospitals in America
Via ACCESSWIRE
Biotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024
Via ACCESSWIRE
Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st
Via ACCESSWIRE
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Biotricity Advances Towards Breakeven Milestone - Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024
Via ACCESSWIRE
Earnings Scheduled For February 20, 2024
Via Benzinga
Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.